Nimotuzumab in Adults With Pancreatic Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2014

Conditions
Pancreatic Cancer, Advanced or Metastatic
Interventions
DRUG

Nimotuzumab

Trial Locations (1)

44621

Marienhospital Herne, Herne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Marienhospital Herne

OTHER

collaborator

University of Kiel

OTHER

collaborator

Gemeinschaftspraxis für Hämatologie und Onkologie, Köln, Germany

UNKNOWN

collaborator

Onkologisches Zentrum III, Medizinische Klinik, Mannheim, Germany

UNKNOWN

collaborator

Onkologische Gemeinschaftspraxis, Mülheim, Germany

UNKNOWN

collaborator

II. Medizinische Klinik u. Poliklinik, Klinikum rechts der Isar, München, Germany

UNKNOWN

collaborator

Hämatologisch-Onkologische Schwerpunktpraxis, Münster, Germany

UNKNOWN

collaborator

Praxis für Internistische Onkologie und Hämatologie, Recklinghausen, Germany

UNKNOWN

lead

Oncoscience AG

INDUSTRY